Press Releases
-
ChargePoint Technology’s new facility expands into Europe
-
Medix Biochemica broadens its capabilities in diagnostic base matrices through the acquisition of Bioresource Technology
Medix Biochemica has acquired 100 percent of the shares of Bioresource Technology (“BRT”).
Jun 19, 2022
-
Biopharma PEG Provides Monodisperse PEGs In Drug Development
The team of Biopharma PEG Scientific Inc. owns the most qualified and talented synthetic and medicinal chemists. We can provide a wide range of high purity monodispersed PEG products of multi functionalized groups in milligram to hundreds of kilograms or greater with GMP standard manufacturing capability.
Jun 19, 2022
-
Huateng Pharma Supplies Pemetrexed Intermeidates Against NSCLC
Pemetrexed is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC). It is also being studied in the treatment of other types of cancer. Huateng Pharma supplies some intermeidates of Pemetrexed.
Jun 19, 2022
-
Terracon Appoint Quality Engineering Manager to Facilitate Growth and Continued Customer Satisfaction
-
Alfa Chemistry Releases Chemical Fluorophores for Bioanalysis, Environmental Monitoring, Clinical Diagnosis and Fluorescence Staining
Earlier this month, the management of Alfa Chemistry announced the launch of varieties of chemical fluorophores for researchers worldwide. Those newly released fluorophores, including BODIPY fluorophores, cyanine fluorophores, rhodamine fluorophores, and fluorescein fluorophores, can be widely used for bioanalysis, environmental monitoring, clinical diagnosis, fluorescence staining, as well as other application scenarios.
Jun 15, 2022
-
Rapid Profound Hypothermia (Suspended Animation) is in Clinical Trials as a New, Innovative Approach to Emergency Care When Cardiopulmonary Resuscitation (CPR) Fails
EPR-Technologies has announced its pursuit of the development of an unprecedented standard of emergency care when CPR fails.
Jun 15, 2022
-
C. elegans Lysis/DNA Extraction Kits Available at Creative Biogene
Creative Biogene recently developed the C. elegans lysis/DNA extraction kits (CDC-k108) are now available to worldwide clients and partners.
Jun 19, 2022
-
Obtaining High-yield and Bioactive B. subtilis Bioproducts with Creative Biogene’s Cultivation Support
Creative Biogene announced the release of Bacillus subtilis cultivation service using flexible fermentation and cultivation strategies to help customers in obtaining high-yield and bioactive B. subtilis bioproducts.
Jun 14, 2022
-
mdgroup appoints LaQuinta Jernigan as Chief Operating Officer
mdgroup appoints LaQuinta Jernigan as Chief Operating Officer Executive leadership appointment to drive seamless client experiences in patient- servicing and digitally enabled clinical trials
Jun 13, 2022
-
Alok Sharma MP officially opens Tower Cold Chain’s global HQ
The global headquarters of pharmaceutical thermal protection specialist Tower Cold Chain has been officially opened by The Rt Hon Alok Sharma, Member of Parliament for Reading West.
Jun 13, 2022
-
Andaman7 argues case for greater patient mediated research at HIMSS European Health Conference 2022
-
CytoSMART Technologies Introduces Machine-Learning Algorithm for Organoid Analysis on the CytoSMART Omni Systems
CytoSMART Technologies announced the launch of a new Organoid Analysis Module for use with its flagship CytoSMART Omni live-cell imaging product line.
Jun 9, 2022
-
Calyx Named Medical Imaging Provider by Clinscience
Clinscience extends Calyx’s reliable, expedited imaging services to its global pharmaceutical customers
Jun 8, 2022
-
mdgroup recognised as one of the UK's fastest-growing private companies
mdgroup recognised as one of the UK's fastest-growing private companies 9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.
Jun 8, 2022
-
CordenPharma Increases xRNA-based Capabilities with a Strategic Investment in LNP Formulation Services at its Caponago Injectable Facility
CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy.
Jun 9, 2022
-
Terumo Pharmaceutical Solutions offers pre-fillable syringe solutions for demanding low dose applications such as ophthalmic
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.
Jun 9, 2022
-
ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2
ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2.
Jun 6, 2022
-
Veeva Announces Clinical Study Training Application
Veeva Systems announces new application, Veeva Vault Study Training, for integrated and automated clinical training.
Jun 6, 2022
-
Abzena Selects IPS for Turnkey Delivery of New CGMP Facility in North Carolina
IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina
Jun 7, 2022